apomorphine has been researched along with alprostadil in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.54) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 19 (73.08) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Costall, B; Holmes, SW; Kelly, ME; Naylor, RJ | 1 |
| Berry-Kravis, E; Dawson, G; Freedman, SB | 1 |
| Moncada Iribarren, I; Sáenz de Tejada, I | 1 |
| Cohan, P; Korenman, SG | 1 |
| Hatzichristou, DG; Pescatori, ES | 1 |
| Thomas, JA | 1 |
| Lyngdorf, P | 1 |
| Giraldi, AG; Gregersen, N; Hilmand, CB | 1 |
| Anastasiadis, AG; Shabsigh, R | 1 |
| Cestari, A; Deho', F; Guazzoni, G; Montorsi, F; Rigatti, P; Salonia, A; Stief, C | 1 |
| Hauri, D; Müntener, M; Praz, V; Suter, S | 1 |
| Erdei, E; Papp, G | 1 |
| Steers, WD | 1 |
| Gaines, KK | 1 |
| Schultheiss, D; Stief, CG | 1 |
| Jackson, G | 1 |
| Engelmann, U; Sommer, F | 1 |
| Hatzichristou, DG; Hatzimouratidis, K | 1 |
| Xu, G; Xu, Y | 1 |
| Landtblom, AM | 1 |
| Gopalakrishanan, G; Tharyan, P | 1 |
| Görlich, HD; Potempa, DM; Potempal, AJ; Stolpmann, RM | 1 |
| Farmer, M; Goldstein, I; Yoon, H | 1 |
15 review(s) available for apomorphine and alprostadil
| Article | Year |
|---|---|
Pharmacological treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Muscle Relaxation; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 1999 |
Erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Androgens; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Prevalence; Vasodilator Agents | 2001 |
Current treatments and emerging therapeutic approaches in male erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Male; Penile Implantation; Physical Therapy Modalities; Piperazines; Psychotherapy; Purines; Sildenafil Citrate; Sulfones; Testosterone; Triazines; Vacuum; Vardenafil Dihydrochloride; Vascular Surgical Procedures; Vasodilator Agents; Yohimbine | 2001 |
Pharmacological aspects of erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Apomorphine; Drug Interactions; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Trazodone | 2002 |
Erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Alprostadil; Apomorphine; Brain; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Penile Prosthesis; Penis; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2003 |
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Carbolines; Drug Combinations; Erectile Dysfunction; Humans; Imidazoles; Injections; Male; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2003 |
[Erectile dysfunction: reasonable diagnostics and treatment in general practice].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Age Factors; Aged; Algorithms; Alprostadil; Apomorphine; Cohort Studies; Contraindications; Dopamine Agonists; Erectile Dysfunction; Family Practice; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Piperazines; Purines; Risk Factors; Sexual Partners; Sildenafil Citrate; Sulfones; Vasodilator Agents; Yohimbine | 2003 |
[Conservative treatment of erectile dysfunction].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Imidazoles; Impotence, Vasculogenic; Injections; Male; Nitric Oxide; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Psychotherapy; Purines; Sildenafil Citrate; Sulfones; Triazines; Vacuum; Vardenafil Dihydrochloride; Vasodilator Agents | 2003 |
Viability and safety of combination drug therapies for erectile dysfunction.
Topics: Alprostadil; Apomorphine; Dopamine Agonists; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2003 |
Sexual dysfunction and diabetes.
Topics: Alprostadil; Apomorphine; Diabetes Complications; Diabetes Mellitus; Erectile Dysfunction; Humans; Life Style; Male; Medical History Taking; Penile Prosthesis; Phosphodiesterase Inhibitors; Risk Factors; Self Administration; Testosterone; Vacuum | 2004 |
Future options for combination therapy in the management of erectile dysfunction in older men.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Aged; Alprostadil; Animals; Apomorphine; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Dopamine Agonists; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Testosterone | 2004 |
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Topics: Administration, Oral; Alprostadil; Apomorphine; Carbolines; Constriction; Contraindications; Dopamine Agonists; Drug Combinations; Enzyme Inhibitors; Erectile Dysfunction; Humans; Imidazoles; Male; Papaverine; Patient Satisfaction; Penile Prosthesis; Penis; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Regional Blood Flow; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Failure; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2005 |
Treatment of erectile dysfunction in multiple sclerosis.
Topics: Alprostadil; Apomorphine; Dopamine Agents; Erectile Dysfunction; Humans; Male; Multiple Sclerosis; Phosphodiesterase Inhibitors; Psychotherapy; Vasodilator Agents | 2006 |
Erectile dysfunction.
Topics: Adult; Alprostadil; Apomorphine; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Penile Erection; Penile Prosthesis; Piperazines; Purines; Sex Counseling; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Yohimbine | 2006 |
Future Targets for Female Sexual Dysfunction.
Topics: Alprostadil; Anxiety; Aphrodisiacs; Apomorphine; Consensus; Dehydroepiandrosterone; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Forecasting; Humans; Melanocortins; Neurotransmitter Agents; Nitric Oxide Donors; Pelvic Pain; Pharmacogenomic Testing; Phosphodiesterase 5 Inhibitors; Psychotherapy; Serotonin; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Testosterone; Transcranial Magnetic Stimulation | 2016 |
1 trial(s) available for apomorphine and alprostadil
| Article | Year |
|---|---|
[Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Topics: Aged; Aged, 80 and over; Alprostadil; Apomorphine; Body Mass Index; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Orgasm; Penile Erection; Phosphodiesterase Inhibitors; Postoperative Complications; Quality of Life; Urethra; Vasodilator Agents | 2007 |
10 other study(ies) available for apomorphine and alprostadil
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
Topics: Alprostadil; Animals; Apomorphine; Corpus Striatum; Dinoprost; Dinoprostone; Dopamine; Dyskinesia, Drug-Induced; Functional Laterality; Guinea Pigs; Male; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Tetrahydronaphthalenes | 1985 |
Specific receptor-mediated inhibition of cyclic AMP synthesis by dopamine in a neuroblastoma X brain hybrid cell line NCB-20.
Topics: Alprostadil; Animals; Apomorphine; Brain; Cell Line; Cell Membrane; Clonidine; Cricetinae; Cricetulus; Cyclic AMP; Dopamine; Hybrid Cells; Mice; Neuroblastoma; Prostaglandins E; Receptors, Dopamine; Serotonin; Spiperone | 1984 |
[Erectile dysfunction].
Topics: Adrenergic beta-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Genetic Therapy; Humans; Impotence, Vasculogenic; Male; Penile Erection; Phosphodiesterase Inhibitors; Vasodilator Agents; Yohimbine | 2002 |
[Pharmacological treatment of sexual dysfunction in women].
Topics: Adrenergic beta-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Female; Humans; Phentolamine; Phosphodiesterase Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Vasodilator Agents | 2002 |
Coming attractions! New medications on the horizon for erectile dysfunction.
Topics: Alprostadil; Apomorphine; Carbolines; Drug Approval; Erectile Dysfunction; Genetic Therapy; Global Health; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil; United States; United States Food and Drug Administration | 2003 |
[Drug therapy of erectile dysfunction--the current status].
Topics: Administration, Oral; Administration, Topical; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Vasodilator Agents; Yohimbine | 2003 |
[Determination of apomorphine, sildenafil and alprostadil in medicines for erectile dysfunction by high performance liquid chromatography-mass spectrometry].
Topics: Alprostadil; Apomorphine; Chromatography, High Pressure Liquid; Dopamine Agonists; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Male; Mass Spectrometry; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2005 |